300 related articles for article (PubMed ID: 24706986)
1. Targeting the myofibroblast genetic switch: inhibitors of myocardin-related transcription factor/serum response factor-regulated gene transcription prevent fibrosis in a murine model of skin injury.
Haak AJ; Tsou PS; Amin MA; Ruth JH; Campbell P; Fox DA; Khanna D; Larsen SD; Neubig RR
J Pharmacol Exp Ther; 2014 Jun; 349(3):480-6. PubMed ID: 24706986
[TBL] [Abstract][Full Text] [Related]
2. Prostaglandin E2 inhibits α-smooth muscle actin transcription during myofibroblast differentiation via distinct mechanisms of modulation of serum response factor and myocardin-related transcription factor-A.
Penke LR; Huang SK; White ES; Peters-Golden M
J Biol Chem; 2014 Jun; 289(24):17151-62. PubMed ID: 24802754
[TBL] [Abstract][Full Text] [Related]
3. Umbilical cord/placenta-derived mesenchymal stem cells inhibit fibrogenic activation in human intestinal myofibroblasts via inhibition of myocardin-related transcription factor A.
Choi YJ; Koo JB; Kim HY; Seo JW; Lee EJ; Kim WR; Cho JY; Hahm KB; Hong SP; Kim DH; Yoo JH
Stem Cell Res Ther; 2019 Sep; 10(1):291. PubMed ID: 31547873
[TBL] [Abstract][Full Text] [Related]
4. Novel Rho/MRTF/SRF inhibitors block matrix-stiffness and TGF-β-induced fibrogenesis in human colonic myofibroblasts.
Johnson LA; Rodansky ES; Haak AJ; Larsen SD; Neubig RR; Higgins PD
Inflamm Bowel Dis; 2014 Jan; 20(1):154-65. PubMed ID: 24280883
[TBL] [Abstract][Full Text] [Related]
5. Inhibition of myocardin-related transcription factor/serum response factor signaling decreases lung fibrosis and promotes mesenchymal cell apoptosis.
Sisson TH; Ajayi IO; Subbotina N; Dodi AE; Rodansky ES; Chibucos LN; Kim KK; Keshamouni VG; White ES; Zhou Y; Higgins PD; Larsen SD; Neubig RR; Horowitz JC
Am J Pathol; 2015 Apr; 185(4):969-86. PubMed ID: 25681733
[TBL] [Abstract][Full Text] [Related]
6. A Role of Myocardin Related Transcription Factor-A (MRTF-A) in Scleroderma Related Fibrosis.
Shiwen X; Stratton R; Nikitorowicz-Buniak J; Ahmed-Abdi B; Ponticos M; Denton C; Abraham D; Takahashi A; Suki B; Layne MD; Lafyatis R; Smith BD
PLoS One; 2015; 10(5):e0126015. PubMed ID: 25955164
[TBL] [Abstract][Full Text] [Related]
7. Lysophosphatidic acid signaling through its receptor initiates profibrotic epithelial cell fibroblast communication mediated by epithelial cell derived connective tissue growth factor.
Sakai N; Chun J; Duffield JS; Lagares D; Wada T; Luster AD; Tager AM
Kidney Int; 2017 Mar; 91(3):628-641. PubMed ID: 27927603
[TBL] [Abstract][Full Text] [Related]
8. Hope for disease-modifying treatment of systemic sclerosis/scleroderma.
Michel MC
J Pharmacol Exp Ther; 2014 Sep; 350(3):480-2. PubMed ID: 25053235
[No Abstract] [Full Text] [Related]
9. Myocardin-related transcription factor-A complexes activate type I collagen expression in lung fibroblasts.
Luchsinger LL; Patenaude CA; Smith BD; Layne MD
J Biol Chem; 2011 Dec; 286(51):44116-44125. PubMed ID: 22049076
[TBL] [Abstract][Full Text] [Related]
10. Delayed stress fiber formation mediates pulmonary myofibroblast differentiation in response to TGF-β.
Sandbo N; Lau A; Kach J; Ngam C; Yau D; Dulin NO
Am J Physiol Lung Cell Mol Physiol; 2011 Nov; 301(5):L656-66. PubMed ID: 21856814
[TBL] [Abstract][Full Text] [Related]
11. Pharmacokinetic optimitzation of CCG-203971: Novel inhibitors of the Rho/MRTF/SRF transcriptional pathway as potential antifibrotic therapeutics for systemic scleroderma.
Hutchings KM; Lisabeth EM; Rajeswaran W; Wilson MW; Sorenson RJ; Campbell PL; Ruth JH; Amin A; Tsou PS; Leipprandt JR; Olson SR; Wen B; Zhao T; Sun D; Khanna D; Fox DA; Neubig RR; Larsen SD
Bioorg Med Chem Lett; 2017 Apr; 27(8):1744-1749. PubMed ID: 28285914
[TBL] [Abstract][Full Text] [Related]
12. Myocardin and myocardin-related transcription factor-A synergistically mediate actin cytoskeletal-dependent inhibition of liver fibrogenesis.
Shi Z; Ren M; Rockey DC
Am J Physiol Gastrointest Liver Physiol; 2020 Mar; 318(3):G504-G517. PubMed ID: 31928221
[TBL] [Abstract][Full Text] [Related]
13. 5-Aryl-1,3,4-oxadiazol-2-ylthioalkanoic Acids: A Highly Potent New Class of Inhibitors of Rho/Myocardin-Related Transcription Factor (MRTF)/Serum Response Factor (SRF)-Mediated Gene Transcription as Potential Antifibrotic Agents for Scleroderma.
Kahl DJ; Hutchings KM; Lisabeth EM; Haak AJ; Leipprandt JR; Dexheimer T; Khanna D; Tsou PS; Campbell PL; Fox DA; Wen B; Sun D; Bailie M; Neubig RR; Larsen SD
J Med Chem; 2019 May; 62(9):4350-4369. PubMed ID: 30951312
[TBL] [Abstract][Full Text] [Related]
14. Pivotal role of connective tissue growth factor in lung fibrosis: MAPK-dependent transcriptional activation of type I collagen.
Ponticos M; Holmes AM; Shi-wen X; Leoni P; Khan K; Rajkumar VS; Hoyles RK; Bou-Gharios G; Black CM; Denton CP; Abraham DJ; Leask A; Lindahl GE
Arthritis Rheum; 2009 Jul; 60(7):2142-55. PubMed ID: 19565505
[TBL] [Abstract][Full Text] [Related]
15. The Purα/Purβ single-strand DNA-binding proteins attenuate smooth-muscle actin gene transactivation in myofibroblasts.
Hariharan S; Kelm RJ; Strauch AR
J Cell Physiol; 2014 Sep; 229(9):1256-71. PubMed ID: 24446247
[TBL] [Abstract][Full Text] [Related]
16. The nuclear receptor constitutive androstane receptor/NR1I3 enhances the profibrotic effects of transforming growth factor β and contributes to the development of experimental dermal fibrosis.
Avouac J; Palumbo-Zerr K; Ruzehaji N; Tomcik M; Zerr P; Dees C; Distler A; Beyer C; Schneider H; Distler O; Schett G; Allanore Y; Distler JH
Arthritis Rheumatol; 2014 Nov; 66(11):3140-50. PubMed ID: 25155144
[TBL] [Abstract][Full Text] [Related]
17. Local delivery of novel MRTF/SRF inhibitors prevents scar tissue formation in a preclinical model of fibrosis.
Yu-Wai-Man C; Spencer-Dene B; Lee RMH; Hutchings K; Lisabeth EM; Treisman R; Bailly M; Larsen SD; Neubig RR; Khaw PT
Sci Rep; 2017 Mar; 7(1):518. PubMed ID: 28364121
[TBL] [Abstract][Full Text] [Related]
18. Connective tissue growth factor causes persistent proalpha2(I) collagen gene expression induced by transforming growth factor-beta in a mouse fibrosis model.
Chujo S; Shirasaki F; Kawara S; Inagaki Y; Kinbara T; Inaoki M; Takigawa M; Takehara K
J Cell Physiol; 2005 May; 203(2):447-56. PubMed ID: 15605379
[TBL] [Abstract][Full Text] [Related]
19. CD44 inhibits α-SMA gene expression via a novel G-actin/MRTF-mediated pathway that intersects with TGFβR/p38MAPK signaling in murine skin fibroblasts.
Wang Y; Mack JA; Maytin EV
J Biol Chem; 2019 Aug; 294(34):12779-12794. PubMed ID: 31285260
[TBL] [Abstract][Full Text] [Related]
20. Inhibition of activator protein 1 signaling abrogates transforming growth factor β-mediated activation of fibroblasts and prevents experimental fibrosis.
Avouac J; Palumbo K; Tomcik M; Zerr P; Dees C; Horn A; Maurer B; Akhmetshina A; Beyer C; Sadowski A; Schneider H; Shiozawa S; Distler O; Schett G; Allanore Y; Distler JH
Arthritis Rheum; 2012 May; 64(5):1642-52. PubMed ID: 22139817
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
